| Range: | 30.005-98.0 | Vol Avg: | 119376 | Last Div: | 0 | Changes: | 1.69 |
| Beta: | 0 | Cap: | 0.49B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Oct 03 2019 | Empoloyees: | 101 | ||
| CUSIP: | 500946108 | CIK: | 0001703647 | ISIN: | US5009461089 | Country: | US |
| CEO: | Mr. Ram Aiyar MBA, Ph.D. | Website: | https://www.korrobio.com | ||||
KRRO 52.36 Stock Price Korro Bio, Inc.
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Stock Details
Neutral 0.10
Korro to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO)...
globenewswire.com·Thu Nov 21 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow